SCHEMBL5320936

SCHEMBL5320936

C=CCSC(O)C(O)CO

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP3A4 P08684 2/20 0.33
HPGD P15428 2/20 0.33
ALOX15 P16050 1/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALOX5 P09917 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5936412 0.72
SCHEMBL88154 0.67
SCHEMBL7028189 0.67
SCHEMBL6469555 0.67
Diallyl Sulfide SCHEMBL9376569 0.65 ALOX5 (0.58) TRPA1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL11031750 0.65
SCHEMBL4239375 0.64 TRPA1 (0.47) TRPA1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL75409 0.64 LMNA (0.47) ALDH1A1LMNAL3MBTL1TDP1
SCHEMBL1270185 0.64 LMNA (0.47) ALDH1A1LMNAL3MBTL1TDP1
SCHEMBL30535 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011011710-A1 METHODS OF TREATING VIRAL INFECTIONS CHIMERIX, INC. (US) 2011-01-27 WO claimed
EP-2841162-A1 A METHOD OF MITIGATING VIRUS ASSOCIATED END-ORGAN DAMAGE Chimerix, Inc. (US) 2015-03-04 EP disclosed
EP-2770834-A1 HEXADECYLOXYPROPYL CIDOFOVIR FOR THE TREATMENT OF DOUBLE-STRANDED DNA VIRUS INFECTION Chimerix, Inc. (US) 2014-09-03 EP disclosed
WO-2013163509-A1 A METHOD OF MITIGATING VIRUS ASSOCIATED END-ORGAN DAMAGE CHIMERIX, INC. (US) 2013-10-31 WO disclosed
WO-2013063436-A1 HEXADECYLOXYPROPYL CIDOFOVIR FOR THE TREATMENT OF DOUBLE-STRANDED DNA VIRUS INFECTION CHIMERIX, INC. (US) 2013-05-02 WO disclosed
EP-1868628-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF POXVIRUS INFECTIONS Chimerix, Inc. (US) 2007-12-26 EP disclosed
WO-2006110655-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF POXVIRUS INFECTIONS CHIMERIX, INC. (US) 2006-10-19 WO disclosed
US-5851548-A Liposomes containing cationic lipids and vitamin D GEN-PROBE INCORPORATED (US) 1998-12-22 US disclosed
US-5759519-A Method for the intracellular delivery of biomolecules using thiocationic lipids GEN-PROBE INCORPORATED (US) 1998-06-02 US disclosed
US-5756352-A CATIONIC CHARGES FOR LIPIDS USED IN DIAGNOSIS GEN-PROBE INCORPORATED (US) 1998-05-26 US disclosed
US-5739271-A DRUG DELIVERY OF OLIGONUCLEOTIDES, NUCLEIC ACIDS, PEPTIDES, IMAGES, AND PROTEINS GEN-PROBE INCORPORATED (US) 1998-04-14 US disclosed
US-5711964-A CELLULAR METABOLISM AND CATIONIC LIPIDS UNITED STATES OF AMERICA (US) 1998-01-27 US disclosed
WO-1996040627-A2 THIOCATIONIC LIPIDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF GEN-PROBE INCORPORATED (US) 1996-12-19 WO disclosed
EP-0747351-A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof GEN-PROBE INCORPORATED (US) 1996-12-11 EP disclosed
US-4087466-A NONIONIC SURFACTANTS L'OREAL (FR) 1978-05-02 US disclosed
US-4058629-A Polyhydroxyl monosulfoxide shampoo compositions L'OREAL (FR) 1977-11-15 US disclosed
US-3984480-A Polyhydroxyl monosulfoxide surfactant L'OREAL (FR) 1976-10-05 US disclosed
US-3966398-A Hair dyeing composition containing a non-ionic surfactant L'OREAL (FR) 1976-06-29 US disclosed